Larimar Therapeutics to Present at the Guggenheim 5th Annual Inflammation, Neurology & Immunology Conference

Larimar Therapeutics

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced that members of the company’s management team will participate in a fireside chat and 1×1 investor meetings at the Guggenheim 5th Annual Inflammation, Neurology & Immunology Conference, taking place in New York, NY from November 6 – 7, 2023.

Details on the fireside chat can be found below.

Date: Tuesday, November 7, 2023
Time: 1:10 – 1:40 PM ET
Webcast Link: https://guggenheim.metameetings.net/events/ini23

Following the conclusion of the fireside chat, a replay will be available for 30 days on the “Events and Presentations” page of Larimar’s website.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  INOVIO Announces Promising Immunology Data for INO-3107 in RRP Treatment